{"gene":"RABGGTB","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1993,"finding":"RABGGTB encodes the beta subunit of the catalytic Component B (a heterodimer of alpha and beta subunits) of Rab geranylgeranyl transferase (RabGGTase). When the rat alpha and beta subunit cDNAs were co-transfected into 293 cells, the expressed protein produced RabGGTase activity stimulated by Component A (REP). The beta subunit (331 aa) is the yeast BET2 ortholog.","method":"cDNA cloning, heterologous co-expression in 293 cells, in vitro enzymatic activity assay","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted enzymatic activity in cells, foundational cloning paper, >89 citations","pmids":["8505342"],"is_preprint":false},{"year":1993,"finding":"Choroideremia (X-linked retinal degeneration) results from deficiency of Component A (REP-1) of RabGGTase, leaving Component B (which contains RABGGTB) intact. Lymphoblasts from choroideremia patients showed markedly deficient Component A activity but normal Component B activity, establishing that the two components are functionally separable and that RABGGTB-containing Component B activity is unaffected.","method":"Enzymatic activity assay in patient lymphoblasts, biochemical fractionation","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — direct enzymatic assay in patient cells, >297 citations, foundational study","pmids":["8380507"],"is_preprint":false},{"year":1994,"finding":"RabGGTase (containing RABGGTB) catalyzes geranylgeranylation of both adjacent C-terminal cysteines in Rab1A (-XXCC), Rab3A (-XCXC), and Rab5A (-CCXX), as confirmed by HPLC and electrospray mass spectrometry of in vitro prenylated tryptic peptides.","method":"In vitro prenylation assay with recombinant enzyme, HPLC, electrospray mass spectrometry","journal":"Proceedings of the National Academy of Sciences of the USA","confidence":"High","confidence_rationale":"Tier 1 — direct structural analysis of in vitro reaction products, >134 citations","pmids":["7991565"],"is_preprint":false},{"year":1994,"finding":"RabGGTase processing of Rab6 requires the loop3/beta3 region and the hypervariable C-terminal region of Rab6 but not the effector domain, defining sequence requirements for substrate recognition by the RABGGTB-containing enzyme. Rab6 proteins geranylgeranylated on CXC or CC motifs were significantly better substrates for RabGDI extraction than those prenylated on CAAL motifs.","method":"In vitro prenylation assay with Rab6 deletion/substitution mutants, membrane extraction assays with RabGDI","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro mutagenesis coupled to enzymatic assay, >60 citations","pmids":["8175798"],"is_preprint":false},{"year":2003,"finding":"The crystal structure of isoprenoid-bound RabGGTase (containing both alpha and RABGGTB subunits) complexed with REP-1 was solved at 2.7 Å. The RabGGTase–REP-1 interface buries ~680 Å² and is formed by helices 8, 10, and 12 of the RabGGTase alpha subunit and helices D and E of REP-1. The affinity of RabGGTase for REP-1 is allosterically regulated by the phosphoisoprenoid substrate via a long-range trans-domain signal transduction mechanism.","method":"X-ray crystallography (2.7 Å), biochemical binding assays","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with functional validation of allostery, >98 citations","pmids":["12620235"],"is_preprint":false},{"year":2003,"finding":"Di-geranylgeranyl modification catalyzed by RabGGTase (containing RABGGTB) is essential for correct targeting of Rab5a to endosomes and Rab27a to melanosomes; mono-cysteine Rab mutants are mistargeted to the ER and are non-functional in vivo, demonstrating that the RABGGTB-dependent double prenylation provides targeting information.","method":"Transient expression of EGFP-Rab mutants in HeLa cells, CAAX prenyl transferase inhibition, temperature-shift experiments, transgenic rescue assay in Rab27a-null mice","journal":"Molecular Biology of the Cell","confidence":"High","confidence_rationale":"Tier 2 — live-cell imaging + in vivo rescue assay + pharmacological inhibition, >129 citations","pmids":["12802062"],"is_preprint":false},{"year":2008,"finding":"The beta-subunit of Rab geranylgeranyl transferase (RABGGTB) interacts with the cytoplasmic domain of chondrolectin (CHODL), identified by a complete Sos Recruitment System (SRS) yeast two-hybrid screen (8 independent isolates) and confirmed by in vitro transcription/translation and co-immunoprecipitation.","method":"Yeast two-hybrid (SRS screen), in vitro transcription/translation, co-immunoprecipitation","journal":"Cellular & Molecular Biology Letters","confidence":"Medium","confidence_rationale":"Tier 3 — Y2H validated by co-IP; single lab, single study","pmids":["18161010"],"is_preprint":false},{"year":2019,"finding":"RABGGTB (the catalytic beta subunit of RabGGTase) forms a previously unknown prenyltransferase complex with the orphan alpha subunit PTAR1, named GGTase3. This complex specifically geranylgeranylates FBXL2 (a CaaX-motif F-box protein) to enable its membrane localization, where FBXL2 mediates polyubiquitylation of membrane-anchored proteins. Crystal structure of the full-length GGTase3–FBXL2–SKP1 complex reveals that substrate specificity is determined by an extensive multivalent interface between the LRR domain of FBXL2 and PTAR1, not through the CaaX motif alone.","method":"Co-IP, in vitro prenylation assay, subcellular fractionation/localization, X-ray crystallography of ternary complex, mutagenesis","journal":"Nature Structural & Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted enzymatic activity + crystal structure + mutagenesis + cellular functional assay in one study","pmids":["31209342"],"is_preprint":false},{"year":2020,"finding":"GGTase-III (PTAR1 + RABGGTB) geranylgeranylates the Golgi SNARE Ykt6, converting mono-farnesylated Ykt6 to a doubly prenylated form. In GGTase-III-deficient cells, Ykt6 remained singly prenylated, Golgi SNARE complex assembly was severely impaired, and Golgi apparatus structure and intra-Golgi protein trafficking were disrupted. Crystal structure of GGTase-III in complex with Ykt6 provides structural basis for double prenylation.","method":"Biotinylated geranylgeranyl analogue labeling, in vitro prenylation assay, X-ray crystallography, gene knockout cell lines, Golgi trafficking assays","journal":"The EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 — crystal structure + reconstituted activity + KO cell phenotype with defined trafficking readout","pmids":["32128853"],"is_preprint":false},{"year":2023,"finding":"Overexpression of RABGGTB in NSC34-hSOD1G93A and TDP-43 ALS cell models improved cell proliferation and promoted autophagosome-lysosome fusion by enhancing geranylgeranylation of Rab7, and reduced abnormal SOD1 protein aggregation, placing RABGGTB-mediated Rab7 prenylation upstream of autophagy flux in motor neurons.","method":"Lentiviral overexpression, immunofluorescence, cell proliferation assay, autophagy flux analysis in cell lines","journal":"Brain Research Bulletin","confidence":"Medium","confidence_rationale":"Tier 2/3 — defined cellular phenotype with pathway placement (Rab7 prenylation → autophagy), single lab","pmids":["38042502"],"is_preprint":false},{"year":2023,"finding":"Intrathecal injection of AAV9-RabGGTB in SOD1G93A mice increased RABGGTB protein in spinal cord motoneurons, delayed disease onset and extended survival, and reduced misfolded SOD1 aggregation and glial overactivation, demonstrating that RABGGTB overexpression is neuroprotective in vivo in an ALS model.","method":"AAV-mediated gene overexpression in mice, immunofluorescence, behavioral tests (rotarod, footprint, neurological scoring), survival analysis","journal":"Frontiers in Aging Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo KO/overexpression with defined phenotypic readouts; single lab","pmids":["36967828"],"is_preprint":false},{"year":2025,"finding":"Both subunits of GGTase-III (PTAR1 and RABGGTB) are expressed in human islets, mouse islets, and INS-1 832/13 cells. siRNA-mediated knockdown of PTAR1 (the alpha subunit that partners with RABGGTB) reduced glucose-stimulated insulin secretion by ~60% and KCl-induced insulin secretion by ~69%, and Ykt6 (a GGTase-III substrate) is expressed in these cells, establishing a role for the RABGGTB-containing GGTase-III complex in insulin secretion.","method":"siRNA knockdown, ELISA-based insulin secretion assay, Western blotting in INS-1 cells and primary islets","journal":"Cellular Physiology and Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA KD with defined secretory phenotype; single lab, indirect via alpha-subunit knockdown","pmids":["40598917"],"is_preprint":false}],"current_model":"RABGGTB is the catalytic beta subunit shared by two distinct prenyltransferase complexes: the canonical RabGGTase (with the alpha subunit RABGGTA and accessory REP proteins) that doubly geranylgeranylates Rab GTPases to enable their correct membrane targeting and vesicular trafficking, and GGTase-III (with the alternative alpha subunit PTAR1) that geranylgeranylates non-Rab substrates including FBXL2 (directing its membrane localization and ubiquitin ligase activity) and the Golgi SNARE Ykt6 (generating doubly prenylated Ykt6 essential for Golgi organization); substrate specificity in GGTase-III is determined by an extensive interface between PTAR1 and the LRR domain of FBXL2, and RABGGTB-mediated Rab7 prenylation also regulates autophagic flux downstream of autophagosome-lysosome fusion."},"narrative":{"teleology":[{"year":1993,"claim":"Identification of RABGGTB as the catalytic beta subunit of RabGGTase resolved the molecular identity of the enzyme that prenylates Rab GTPases, establishing that it functions as a heterodimer with an alpha subunit and requires the REP escort protein for activity.","evidence":"cDNA cloning and heterologous co-expression in 293 cells with reconstituted enzymatic activity; complemented by biochemical fractionation in choroideremia patient lymphoblasts showing separable Component A (REP) and Component B (alpha/beta) activities","pmids":["8505342","8380507"],"confidence":"High","gaps":["Structural basis for how RABGGTB engages REP and lipid substrate was unknown","Whether RABGGTB participates in complexes beyond RabGGTase was not considered"]},{"year":1994,"claim":"Demonstration that RabGGTase doubly geranylgeranylates Rab C-terminal di-cysteine motifs (CC, CXC, CCXX) and that substrate recognition depends on the hypervariable C-terminal region established the catalytic product and substrate-selection rules for the RABGGTB-containing enzyme.","evidence":"In vitro prenylation with HPLC/mass spectrometry of Rab1A, Rab3A, Rab5A tryptic peptides; Rab6 deletion/substitution mutagenesis coupled to prenylation and GDI-extraction assays","pmids":["7991565","8175798"],"confidence":"High","gaps":["Atomic-level mechanism of double prenylation was unresolved","In vivo functional consequences of mono- versus di-prenylation were unknown"]},{"year":2003,"claim":"The crystal structure of isoprenoid-bound RabGGTase–REP-1 revealed the allosteric communication between the lipid-binding site and the REP interface, and cell-biological experiments showed that double geranylgeranylation is required for correct Rab targeting to organelles in vivo.","evidence":"X-ray crystallography at 2.7 Å with binding assays; EGFP-Rab mutant localization in HeLa cells, inhibitor treatment, and Rab27a rescue in knockout mice","pmids":["12620235","12802062"],"confidence":"High","gaps":["Whether RABGGTB could function with alternative alpha subunits was not explored","Structural basis for Rab substrate recognition within the active site remained incomplete"]},{"year":2019,"claim":"Discovery that RABGGTB pairs with the orphan alpha subunit PTAR1 to form a second prenyltransferase (GGTase-III) that geranylgeranylates the non-Rab substrate FBXL2 fundamentally expanded the functional repertoire of RABGGTB beyond Rab biology.","evidence":"Co-immunoprecipitation, reconstituted in vitro prenylation, subcellular fractionation, and X-ray crystallography of the GGTase-III–FBXL2–SKP1 ternary complex with mutagenesis","pmids":["31209342"],"confidence":"High","gaps":["Full substrate scope of GGTase-III was unknown","Physiological contexts where GGTase-III versus RabGGTase activity is limiting were uncharacterized"]},{"year":2020,"claim":"Identification of Ykt6 as a second GGTase-III substrate and demonstration that GGTase-III-dependent double prenylation of Ykt6 is required for Golgi SNARE complex assembly established RABGGTB's role in Golgi organization through a non-Rab pathway.","evidence":"Biotinylated geranylgeranyl labeling, in vitro prenylation, X-ray crystallography of GGTase-III–Ykt6, gene-knockout cell lines with Golgi trafficking assays","pmids":["32128853"],"confidence":"High","gaps":["Whether additional SNARE or Golgi-resident proteins are GGTase-III substrates is unknown","Relative contribution of RabGGTase versus GGTase-III to overall RABGGTB function in vivo is unresolved"]},{"year":2023,"claim":"Placing RABGGTB-mediated Rab7 prenylation upstream of autophagosome–lysosome fusion linked RABGGTB to autophagic flux, and in vivo overexpression in SOD1-G93A ALS mice was neuroprotective, extending survival and reducing protein aggregation.","evidence":"Lentiviral overexpression in ALS cell models with autophagy flux assays; AAV9-mediated spinal cord delivery in SOD1-G93A mice with behavioral, survival, and histological readouts","pmids":["38042502","36967828"],"confidence":"Medium","gaps":["Whether the neuroprotective effect is solely Rab7-dependent or also involves GGTase-III substrates is untested","Findings are from single-laboratory studies and have not been independently replicated","Therapeutic relevance to human ALS is unestablished"]},{"year":2025,"claim":"Knockdown of the GGTase-III alpha subunit PTAR1 in pancreatic beta cells severely impaired glucose-stimulated insulin secretion, implicating the RABGGTB-containing GGTase-III complex in regulated exocytosis beyond the nervous system.","evidence":"siRNA knockdown of PTAR1 in INS-1 832/13 cells and primary islets with ELISA-based insulin secretion assays","pmids":["40598917"],"confidence":"Medium","gaps":["RABGGTB itself was not directly knocked down; the effect is inferred indirectly through the alpha subunit","Identity of the GGTase-III substrate(s) responsible for the secretion defect is not established","Independent replication is needed"]},{"year":null,"claim":"The complete substrate repertoire of GGTase-III, the structural basis for how RABGGTB partitions between RabGGTase and GGTase-III in the same cell, and the in vivo consequences of selectively disrupting one complex versus the other remain open questions.","evidence":"","pmids":[],"confidence":"High","gaps":["No systematic substrate screen for GGTase-III has been reported","No structural or kinetic model explains competitive assembly of RABGGTB with RABGGTA versus PTAR1","Conditional knockout studies distinguishing RabGGTase from GGTase-III functions in specific tissues are lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,2,7,8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,7]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,2,7,8]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[5,8]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[9]}],"complexes":["RabGGTase (RABGGTA–RABGGTB)","GGTase-III (PTAR1–RABGGTB)"],"partners":["RABGGTA","PTAR1","CHM","CHML","FBXL2","YKT6","CHODL"],"other_free_text":[]},"mechanistic_narrative":"RABGGTB is the catalytic beta subunit of two distinct protein geranylgeranyltransferase complexes: the canonical Rab geranylgeranyltransferase (RabGGTase, paired with RABGGTA and REP escort proteins) that doubly geranylgeranylates Rab GTPases to direct their membrane targeting and vesicular trafficking, and GGTase-III (paired with PTAR1) that geranylgeranylates non-Rab substrates including FBXL2 and the Golgi SNARE Ykt6 [PMID:8505342, PMID:31209342, PMID:32128853]. Within RabGGTase, RABGGTB catalyzes attachment of two geranylgeranyl groups to C-terminal di-cysteine motifs (CC, CXC, CCXX) of Rab proteins such as Rab1A, Rab5A, Rab6, and Rab27a; this double prenylation is essential for correct organellar targeting and function, as mono-prenylated Rabs are mistargeted and non-functional [PMID:7991565, PMID:12802062]. In the GGTase-III complex, a crystal-structure-defined multivalent interface between PTAR1 and the FBXL2 LRR domain determines substrate specificity, while GGTase-III-dependent double prenylation of Ykt6 is required for Golgi SNARE complex assembly and intra-Golgi trafficking [PMID:31209342, PMID:32128853]. RABGGTB-mediated Rab7 geranylgeranylation also promotes autophagosome–lysosome fusion, and overexpression of RABGGTB in SOD1-G93A ALS mouse models delayed disease onset and reduced protein aggregation [PMID:38042502, PMID:36967828]."},"prefetch_data":{"uniprot":{"accession":"P53611","full_name":"Geranylgeranyl transferase type-2 subunit beta","aliases":["Geranylgeranyl transferase type II subunit beta","GGTase-II-beta","Rab geranyl-geranyltransferase subunit beta","Rab GG transferase beta","Rab GGTase beta","Rab geranylgeranyltransferase subunit beta","Type II protein geranyl-geranyltransferase subunit beta"],"length_aa":331,"mass_kda":36.9,"function":"Catalyzes the transfer of a geranylgeranyl moiety from geranylgeranyl diphosphate to both cysteines of Rab proteins with the C-terminal sequence -XXCC, -XCXC and -CCXX, such as RAB1A, RAB3A, RAB5A and RAB7A (PubMed:7991565). Catalytic subunit of the geranylgeranyl transferase type 3 (GGTase-3) complex (PubMed:31209342, PubMed:32128853). The GGTase-3 complex geranylgeranylates and targets FBXL2 to the cellular membranes, where FBXL2 forms part of the E3 ubiquitin-protein ligase complex SCF(FBXL2) that mediates the degradation of membrane-anchored proteins (PubMed:31209342, PubMed:32128853). The GGTase-3 complex geranylgeranylates Golgi v-SNARE protein YKT6 at 'Cys-194' and this prenylation is required for Golgi SNARE complex assembly (PubMed:32128853)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P53611/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/RABGGTB","classification":"Common Essential","n_dependent_lines":1195,"n_total_lines":1208,"dependency_fraction":0.9892384105960265},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000137955","cell_line_id":"CID000450","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"RABGGTA","stoichiometry":10.0},{"gene":"RAP2C;RAP2A","stoichiometry":0.2},{"gene":"PTAR1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000450","total_profiled":1310},"omim":[{"mim_id":"621024","title":"PROTEIN PRENYLTRANSFERASE ALPHA SUBUNIT REPEAT-CONTAINING PROTEIN 1; PTAR1","url":"https://www.omim.org/entry/621024"},{"mim_id":"606209","title":"YKT6 v-SNARE HOMOLOG; YKT6","url":"https://www.omim.org/entry/606209"},{"mim_id":"605652","title":"F-BOX AND LEUCINE-RICH REPEAT PROTEIN 2; FBXL2","url":"https://www.omim.org/entry/605652"},{"mim_id":"601905","title":"RAB GERANYLGERANYL TRANSFERASE, ALPHA SUBUNIT; RABGGTA","url":"https://www.omim.org/entry/601905"},{"mim_id":"300390","title":"CHM RAB ESCORT PROTEIN; CHM","url":"https://www.omim.org/entry/300390"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/RABGGTB"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P53611","domains":[{"cath_id":"1.50.10.20","chopping":"19-322","consensus_level":"medium","plddt":97.3488,"start":19,"end":322}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P53611","model_url":"https://alphafold.ebi.ac.uk/files/AF-P53611-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P53611-F1-predicted_aligned_error_v6.png","plddt_mean":96.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RABGGTB","jax_strain_url":"https://www.jax.org/strain/search?query=RABGGTB"},"sequence":{"accession":"P53611","fasta_url":"https://rest.uniprot.org/uniprotkb/P53611.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P53611/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P53611"}},"corpus_meta":[{"pmid":"31209342","id":"PMC_31209342","title":"GGTase3 is a newly identified geranylgeranyltransferase targeting a ubiquitin ligase.","date":"2019","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31209342","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18419622","id":"PMC_18419622","title":"Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/18419622","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34254989","id":"PMC_34254989","title":"Expression of Rab Prenylation Pathway Genes and Relation to Disease Progression in Choroideremia.","date":"2021","source":"Translational vision science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/34254989","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29574663","id":"PMC_29574663","title":"Assessment of Protein Prenylation Pathway in Multiple Sclerosis Patients.","date":"2018","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/29574663","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36967828","id":"PMC_36967828","title":"Protective effects of intrathecal injection of AAV9-RabGGTB-GFP+ in SOD1G93A mice.","date":"2023","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36967828","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7544156","id":"PMC_7544156","title":"Studies of cloning, chromosomal mapping, and embryonic expression of the mouse Rab geranylgeranyl transferase beta subunit.","date":"1995","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/7544156","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9031634","id":"PMC_9031634","title":"Studies of the mouse Rab geranylgeranyl transferase beta subunit: gene structure, expression and regulation.","date":"1997","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9031634","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18161010","id":"PMC_18161010","title":"The cytoplasmic domain of chondrolectin interacts with the beta-subunit of Rab geranylgeranyl transferase.","date":"2008","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/18161010","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33260622","id":"PMC_33260622","title":"ChIP-Seq-Based Approach in Mouse Enteric Precursor Cells Reveals New Potential Genes with a Role in Enteric Nervous System Development and Hirschsprung Disease.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33260622","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38042502","id":"PMC_38042502","title":"RABGGTB plays a critical role in ALS pathogenesis.","date":"2023","source":"Brain research bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/38042502","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40324706","id":"PMC_40324706","title":"Exploring genetic and epigenetic markers for predicting or monitoring response to cognitive-behavioral therapy in obsessive-compulsive disorder: A systematic review.","date":"2025","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/40324706","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38002490","id":"PMC_38002490","title":"Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis.","date":"2023","source":"Brain sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38002490","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40272067","id":"PMC_40272067","title":"Genome-wide DNA methylation profiles in the raphe nuclei of patients with autism spectrum disorder.","date":"2025","source":"Psychiatry and clinical neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/40272067","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38751653","id":"PMC_38751653","title":"Sex-based Dysregulation of Inflammation-related Genes in Periodontitis.","date":"2023","source":"International journal of molecular and cellular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38751653","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40712510","id":"PMC_40712510","title":"Significant upregulation of prenyltransferase-related genes in neuromyelitis optica: Diagnostic potential and clinical correlations.","date":"2025","source":"Multiple sclerosis and related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/40712510","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39224887","id":"PMC_39224887","title":"Assessment of Rab geranylgeranyltransferase subunit beta in amyotrophic lateral sclerosis.","date":"2024","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/39224887","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40598917","id":"PMC_40598917","title":"Novel Roles for Geranylgeranyl Transferase-III (GGTase-III) in Insulin Secretion.","date":"2025","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40598917","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17081983","id":"PMC_17081983","title":"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/17081983","citation_count":2861,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8380507","id":"PMC_8380507","title":"Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase.","date":"1993","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/8380507","citation_count":297,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18461144","id":"PMC_18461144","title":"Systematic identification of mRNAs recruited to argonaute 2 by specific microRNAs and corresponding changes in transcript abundance.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18461144","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7991565","id":"PMC_7991565","title":"Rab geranylgeranyl transferase catalyzes the geranylgeranylation of adjacent cysteines in the small GTPases Rab1A, Rab3A, and Rab5A.","date":"1994","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7991565","citation_count":134,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12802062","id":"PMC_12802062","title":"Membrane targeting of Rab GTPases is influenced by the prenylation motif.","date":"2003","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/12802062","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27453043","id":"PMC_27453043","title":"A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27453043","citation_count":113,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20379614","id":"PMC_20379614","title":"Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.","date":"2010","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/20379614","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33545068","id":"PMC_33545068","title":"Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.","date":"2021","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/33545068","citation_count":105,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24035498","id":"PMC_24035498","title":"Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.","date":"2013","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24035498","citation_count":100,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12620235","id":"PMC_12620235","title":"Structure of Rab escort protein-1 in complex with Rab geranylgeranyltransferase.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12620235","citation_count":98,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8505342","id":"PMC_8505342","title":"cDNA cloning and expression of the alpha and beta subunits of rat Rab geranylgeranyl transferase.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8505342","citation_count":89,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29180619","id":"PMC_29180619","title":"The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29180619","citation_count":86,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28515276","id":"PMC_28515276","title":"Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.","date":"2017","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28515276","citation_count":78,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32128853","id":"PMC_32128853","title":"A SNARE geranylgeranyltransferase essential for the organization of the Golgi apparatus.","date":"2020","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/32128853","citation_count":69,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20403997","id":"PMC_20403997","title":"Genetic variation in 3-hydroxy-3-methylglutaryl CoA reductase modifies the chemopreventive activity of statins for colorectal cancer.","date":"2010","source":"Cancer prevention research (Philadelphia, Pa.)","url":"https://pubmed.ncbi.nlm.nih.gov/20403997","citation_count":62,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8175798","id":"PMC_8175798","title":"Determination of structural requirements for the interaction of Rab6 with RabGDI and Rab geranylgeranyltransferase.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8175798","citation_count":60,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28298427","id":"PMC_28298427","title":"Systematic protein-protein interaction mapping for clinically relevant human GPCRs.","date":"2017","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/28298427","citation_count":58,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9965,"output_tokens":1800,"usd":0.028448},"stage2":{"model":"claude-opus-4-6","input_tokens":5089,"output_tokens":2090,"usd":0.116542},"total_usd":0.355757,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":22296,"output_tokens":3292,"usd":0.058134},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6911,"output_tokens":2688,"usd":0.152633}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"RabGGTB (the catalytic β-subunit of GGTase2) forms a novel heterodimeric prenyltransferase complex with the orphan α-subunit PTAR1, named GGTase3, which specifically geranylgeranylates FBXL2 at its C-terminal CaaX motif to enable FBXL2 membrane localization and subsequent polyubiquitylation of membrane-anchored substrates. Crystal structure of the full-length GGTase3-FBXL2-SKP1 complex reveals that substrate specificity is conferred by an extensive multivalent interface between FBXL2's leucine-rich repeat domain and PTAR1.\",\n      \"method\": \"Co-immunoprecipitation, in vitro prenylation assay, crystal structure determination, mutagenesis, cell membrane fractionation\",\n      \"journal\": \"Nature structural & molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution, crystal structure, and mutagenesis in a single rigorous study\",\n      \"pmids\": [\"31209342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"RABGGTB overexpression in NSC34-hSOD1G93A and TDP-43 ALS cell models promotes geranylgeranylation of Rab7, which facilitates autophagosome-lysosome fusion, enhances autophagy, and reduces abnormal SOD1 protein aggregation.\",\n      \"method\": \"Lentiviral overexpression, immunofluorescence, cell proliferation assays, autophagy flux analysis\",\n      \"journal\": \"Brain research bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular phenotype (autophagy, SOD1 clearance) with identified substrate (Rab7), single lab\",\n      \"pmids\": [\"38042502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Intrathecal AAV9-mediated overexpression of RabGGTB in SOD1G93A mice increased RabGGTB protein in spinal cord motoneurons, delayed disease onset and extended survival, and reduced SOD1 misfolding and glial overactivation, consistent with RABGGTB promoting Rab7 prenylation and autophagy in vivo.\",\n      \"method\": \"AAV9-mediated gene delivery, immunofluorescence, behavioral assays (rotarod, footprint), survival analysis in transgenic mice\",\n      \"journal\": \"Frontiers in aging neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain-of-function with defined phenotypic readout, single lab\",\n      \"pmids\": [\"36967828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The cytoplasmic domain of chondrolectin (CHODL) physically interacts with the β-subunit of Rab geranylgeranyl transferase (RABGGTB), identified by SRS yeast two-hybrid screen and confirmed by in vitro transcription/translation and co-immunoprecipitation.\",\n      \"method\": \"SRS yeast two-hybrid screen, in vitro transcription/translation pulldown, co-immunoprecipitation\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — reciprocal Co-IP with two orthogonal binding assays, single lab, no downstream functional consequence defined\",\n      \"pmids\": [\"18161010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GGTase3 (PTAR1/RabGGTB heterodimer) is expressed in pancreatic β-cells (human islets, mouse islets, INS-1 832/13 cells), and siRNA-mediated knockdown of PTAR1 significantly attenuates both glucose-stimulated and KCl-induced insulin secretion, implicating GGTase3-dependent geranylgeranylation (of substrate Ykt6) in insulin exocytosis.\",\n      \"method\": \"Western blotting, siRNA knockdown, ELISA-based insulin secretion assay\",\n      \"journal\": \"Cellular physiology and biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined secretion phenotype; RabGGTB role inferred through its obligate partnership with PTAR1 in GGTase3\",\n      \"pmids\": [\"40598917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The mouse Rab geranylgeranyl transferase β-subunit (Rabggtb) is ubiquitously expressed in adult tissues and shows stage-specific enrichment in developing brain, heart, and liver (E11.5–E13.5); its expression is induced by retinoic acid in P19 embryonal carcinoma cells.\",\n      \"method\": \"In situ hybridization, Northern blot, retinoic acid treatment of P19 cells\",\n      \"journal\": \"Cell growth & differentiation\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — expression/localization data without direct functional mechanistic readout\",\n      \"pmids\": [\"7544156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Cycloheximide treatment dramatically increases the half-life of Rabggtb transcripts (from ~8 h to >12 h), indicating that Rab GGTase β-subunit mRNA stability is regulated post-transcriptionally by a labile repressor protein.\",\n      \"method\": \"Northern blot, actinomycin D mRNA stability assay, cycloheximide treatment\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single method, mechanistic inference at RNA level only\",\n      \"pmids\": [\"9031634\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RABGGTB is the catalytic β-subunit shared by two distinct prenyltransferase complexes: GGTase2 (with RABGGTA), which geranylgeranylates Rab GTPases such as Rab7 to regulate autophagosome-lysosome fusion, and GGTase3 (with the orphan α-subunit PTAR1), which geranylgeranylates non-Rab CaaX substrates including FBXL2 (enabling membrane-localized ubiquitin ligase activity) and Ykt6 (required for insulin secretion); substrate specificity in GGTase3 is dictated by a multivalent interface between PTAR1 and the leucine-rich repeat domain of the substrate, as revealed by crystal structure.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"RABGGTB encodes the beta subunit of the catalytic Component B (a heterodimer of alpha and beta subunits) of Rab geranylgeranyl transferase (RabGGTase). When the rat alpha and beta subunit cDNAs were co-transfected into 293 cells, the expressed protein produced RabGGTase activity stimulated by Component A (REP). The beta subunit (331 aa) is the yeast BET2 ortholog.\",\n      \"method\": \"cDNA cloning, heterologous co-expression in 293 cells, in vitro enzymatic activity assay\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted enzymatic activity in cells, foundational cloning paper, >89 citations\",\n      \"pmids\": [\"8505342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Choroideremia (X-linked retinal degeneration) results from deficiency of Component A (REP-1) of RabGGTase, leaving Component B (which contains RABGGTB) intact. Lymphoblasts from choroideremia patients showed markedly deficient Component A activity but normal Component B activity, establishing that the two components are functionally separable and that RABGGTB-containing Component B activity is unaffected.\",\n      \"method\": \"Enzymatic activity assay in patient lymphoblasts, biochemical fractionation\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct enzymatic assay in patient cells, >297 citations, foundational study\",\n      \"pmids\": [\"8380507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"RabGGTase (containing RABGGTB) catalyzes geranylgeranylation of both adjacent C-terminal cysteines in Rab1A (-XXCC), Rab3A (-XCXC), and Rab5A (-CCXX), as confirmed by HPLC and electrospray mass spectrometry of in vitro prenylated tryptic peptides.\",\n      \"method\": \"In vitro prenylation assay with recombinant enzyme, HPLC, electrospray mass spectrometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the USA\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct structural analysis of in vitro reaction products, >134 citations\",\n      \"pmids\": [\"7991565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"RabGGTase processing of Rab6 requires the loop3/beta3 region and the hypervariable C-terminal region of Rab6 but not the effector domain, defining sequence requirements for substrate recognition by the RABGGTB-containing enzyme. Rab6 proteins geranylgeranylated on CXC or CC motifs were significantly better substrates for RabGDI extraction than those prenylated on CAAL motifs.\",\n      \"method\": \"In vitro prenylation assay with Rab6 deletion/substitution mutants, membrane extraction assays with RabGDI\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro mutagenesis coupled to enzymatic assay, >60 citations\",\n      \"pmids\": [\"8175798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The crystal structure of isoprenoid-bound RabGGTase (containing both alpha and RABGGTB subunits) complexed with REP-1 was solved at 2.7 Å. The RabGGTase–REP-1 interface buries ~680 Å² and is formed by helices 8, 10, and 12 of the RabGGTase alpha subunit and helices D and E of REP-1. The affinity of RabGGTase for REP-1 is allosterically regulated by the phosphoisoprenoid substrate via a long-range trans-domain signal transduction mechanism.\",\n      \"method\": \"X-ray crystallography (2.7 Å), biochemical binding assays\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with functional validation of allostery, >98 citations\",\n      \"pmids\": [\"12620235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Di-geranylgeranyl modification catalyzed by RabGGTase (containing RABGGTB) is essential for correct targeting of Rab5a to endosomes and Rab27a to melanosomes; mono-cysteine Rab mutants are mistargeted to the ER and are non-functional in vivo, demonstrating that the RABGGTB-dependent double prenylation provides targeting information.\",\n      \"method\": \"Transient expression of EGFP-Rab mutants in HeLa cells, CAAX prenyl transferase inhibition, temperature-shift experiments, transgenic rescue assay in Rab27a-null mice\",\n      \"journal\": \"Molecular Biology of the Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — live-cell imaging + in vivo rescue assay + pharmacological inhibition, >129 citations\",\n      \"pmids\": [\"12802062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The beta-subunit of Rab geranylgeranyl transferase (RABGGTB) interacts with the cytoplasmic domain of chondrolectin (CHODL), identified by a complete Sos Recruitment System (SRS) yeast two-hybrid screen (8 independent isolates) and confirmed by in vitro transcription/translation and co-immunoprecipitation.\",\n      \"method\": \"Yeast two-hybrid (SRS screen), in vitro transcription/translation, co-immunoprecipitation\",\n      \"journal\": \"Cellular & Molecular Biology Letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Y2H validated by co-IP; single lab, single study\",\n      \"pmids\": [\"18161010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RABGGTB (the catalytic beta subunit of RabGGTase) forms a previously unknown prenyltransferase complex with the orphan alpha subunit PTAR1, named GGTase3. This complex specifically geranylgeranylates FBXL2 (a CaaX-motif F-box protein) to enable its membrane localization, where FBXL2 mediates polyubiquitylation of membrane-anchored proteins. Crystal structure of the full-length GGTase3–FBXL2–SKP1 complex reveals that substrate specificity is determined by an extensive multivalent interface between the LRR domain of FBXL2 and PTAR1, not through the CaaX motif alone.\",\n      \"method\": \"Co-IP, in vitro prenylation assay, subcellular fractionation/localization, X-ray crystallography of ternary complex, mutagenesis\",\n      \"journal\": \"Nature Structural & Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted enzymatic activity + crystal structure + mutagenesis + cellular functional assay in one study\",\n      \"pmids\": [\"31209342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GGTase-III (PTAR1 + RABGGTB) geranylgeranylates the Golgi SNARE Ykt6, converting mono-farnesylated Ykt6 to a doubly prenylated form. In GGTase-III-deficient cells, Ykt6 remained singly prenylated, Golgi SNARE complex assembly was severely impaired, and Golgi apparatus structure and intra-Golgi protein trafficking were disrupted. Crystal structure of GGTase-III in complex with Ykt6 provides structural basis for double prenylation.\",\n      \"method\": \"Biotinylated geranylgeranyl analogue labeling, in vitro prenylation assay, X-ray crystallography, gene knockout cell lines, Golgi trafficking assays\",\n      \"journal\": \"The EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure + reconstituted activity + KO cell phenotype with defined trafficking readout\",\n      \"pmids\": [\"32128853\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Overexpression of RABGGTB in NSC34-hSOD1G93A and TDP-43 ALS cell models improved cell proliferation and promoted autophagosome-lysosome fusion by enhancing geranylgeranylation of Rab7, and reduced abnormal SOD1 protein aggregation, placing RABGGTB-mediated Rab7 prenylation upstream of autophagy flux in motor neurons.\",\n      \"method\": \"Lentiviral overexpression, immunofluorescence, cell proliferation assay, autophagy flux analysis in cell lines\",\n      \"journal\": \"Brain Research Bulletin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2/3 — defined cellular phenotype with pathway placement (Rab7 prenylation → autophagy), single lab\",\n      \"pmids\": [\"38042502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Intrathecal injection of AAV9-RabGGTB in SOD1G93A mice increased RABGGTB protein in spinal cord motoneurons, delayed disease onset and extended survival, and reduced misfolded SOD1 aggregation and glial overactivation, demonstrating that RABGGTB overexpression is neuroprotective in vivo in an ALS model.\",\n      \"method\": \"AAV-mediated gene overexpression in mice, immunofluorescence, behavioral tests (rotarod, footprint, neurological scoring), survival analysis\",\n      \"journal\": \"Frontiers in Aging Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO/overexpression with defined phenotypic readouts; single lab\",\n      \"pmids\": [\"36967828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Both subunits of GGTase-III (PTAR1 and RABGGTB) are expressed in human islets, mouse islets, and INS-1 832/13 cells. siRNA-mediated knockdown of PTAR1 (the alpha subunit that partners with RABGGTB) reduced glucose-stimulated insulin secretion by ~60% and KCl-induced insulin secretion by ~69%, and Ykt6 (a GGTase-III substrate) is expressed in these cells, establishing a role for the RABGGTB-containing GGTase-III complex in insulin secretion.\",\n      \"method\": \"siRNA knockdown, ELISA-based insulin secretion assay, Western blotting in INS-1 cells and primary islets\",\n      \"journal\": \"Cellular Physiology and Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA KD with defined secretory phenotype; single lab, indirect via alpha-subunit knockdown\",\n      \"pmids\": [\"40598917\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RABGGTB is the catalytic beta subunit shared by two distinct prenyltransferase complexes: the canonical RabGGTase (with the alpha subunit RABGGTA and accessory REP proteins) that doubly geranylgeranylates Rab GTPases to enable their correct membrane targeting and vesicular trafficking, and GGTase-III (with the alternative alpha subunit PTAR1) that geranylgeranylates non-Rab substrates including FBXL2 (directing its membrane localization and ubiquitin ligase activity) and the Golgi SNARE Ykt6 (generating doubly prenylated Ykt6 essential for Golgi organization); substrate specificity in GGTase-III is determined by an extensive interface between PTAR1 and the LRR domain of FBXL2, and RABGGTB-mediated Rab7 prenylation also regulates autophagic flux downstream of autophagosome-lysosome fusion.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RABGGTB is the catalytic β-subunit of protein geranylgeranyltransferase complexes that lipid-modify substrates to enable their membrane association. As part of GGTase2 (with RABGGTA), it geranylgeranylates Rab GTPases such as Rab7, thereby promoting autophagosome–lysosome fusion and clearance of misfolded proteins including SOD1 aggregates in motor neurons [PMID:38042502, PMID:36967828]. RABGGTB also partners with the orphan α-subunit PTAR1 to form GGTase3, a distinct prenyltransferase that geranylgeranylates non-Rab CaaX substrates; crystal structure determination of the GGTase3–FBXL2–SKP1 complex shows that substrate specificity is dictated by a multivalent interface between PTAR1 and the leucine-rich repeat domain of FBXL2 [PMID:31209342]. GGTase3-dependent prenylation of Ykt6 in pancreatic β-cells is required for glucose-stimulated insulin secretion [PMID:40598917].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing that Rabggtb is ubiquitously expressed and developmentally regulated provided the baseline expectation that the β-subunit functions broadly rather than in a restricted tissue context.\",\n      \"evidence\": \"In situ hybridization and Northern blot across mouse embryonic and adult tissues, plus retinoic acid induction in P19 cells\",\n      \"pmids\": [\"7544156\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Expression data alone; no functional or enzymatic readout performed\",\n        \"No loss-of-function experiment to determine developmental requirement\",\n        \"Whether retinoic acid induction reflects a direct transcriptional mechanism is unresolved\"\n      ]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that Rabggtb mRNA is destabilized by a labile protein revealed a post-transcriptional control layer that could tune prenyltransferase capacity, but the identity of the repressor remains unknown.\",\n      \"evidence\": \"Cycloheximide and actinomycin D chase assays measuring mRNA half-life by Northern blot\",\n      \"pmids\": [\"9031634\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Single-method evidence in one cell line; the putative labile repressor protein has not been identified\",\n        \"Functional consequence of altered mRNA stability on prenylation activity not tested\"\n      ]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of CHODL as a physical interactor of RABGGTB raised the possibility that transmembrane proteins can recruit or regulate the prenyltransferase, though the functional significance was not defined.\",\n      \"evidence\": \"SRS yeast two-hybrid, in vitro transcription/translation pulldown, and co-immunoprecipitation\",\n      \"pmids\": [\"18161010\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No downstream functional consequence of the CHODL–RABGGTB interaction was established\",\n        \"Whether CHODL modulates prenylation activity or substrate access is unknown\",\n        \"Interaction not validated in a physiological cellular context\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that RABGGTB forms a second prenyltransferase (GGTase3) with PTAR1, and crystallographic determination of the GGTase3–FBXL2–SKP1 complex, established that a single β-subunit can pair with distinct α-subunits to prenylate non-Rab CaaX substrates with specificity determined by an extensive PTAR1–substrate interface.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro prenylation assay, crystal structure, mutagenesis, membrane fractionation\",\n      \"pmids\": [\"31209342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Full repertoire of GGTase3 substrates beyond FBXL2 not defined\",\n        \"Whether GGTase2 and GGTase3 compete for the shared RABGGTB pool in cells is unresolved\",\n        \"In vivo physiological requirement for GGTase3-mediated FBXL2 prenylation not tested in animal models\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Gain-of-function studies in ALS cell and mouse models showed that RABGGTB overexpression enhances Rab7 prenylation, boosts autophagy flux, and delays disease progression, linking the GGTase2 activity of RABGGTB to protein aggregate clearance in neurodegeneration.\",\n      \"evidence\": \"Lentiviral overexpression in NSC34-hSOD1G93A cells with autophagy markers; AAV9-mediated spinal cord delivery in SOD1G93A mice with survival and behavioral analysis\",\n      \"pmids\": [\"38042502\", \"36967828\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Loss-of-function evidence in motor neurons has not been reported\",\n        \"Whether the protective effect is solely Rab7-dependent or involves additional Rab substrates is unclear\",\n        \"Findings from a single research group; independent replication pending\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrating that GGTase3 (PTAR1/RABGGTB) is required for insulin secretion via prenylation of the SNARE-associated protein Ykt6 expanded the physiological roles of the β-subunit beyond Rab modification to exocytotic membrane fusion.\",\n      \"evidence\": \"siRNA knockdown of PTAR1 in INS-1 832/13 cells and primary islets with ELISA-based insulin secretion readout\",\n      \"pmids\": [\"40598917\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"RABGGTB itself was not directly knocked down; its role is inferred from the obligate heterodimer with PTAR1\",\n        \"Whether Ykt6 is the sole GGTase3 substrate mediating insulin secretion is unresolved\",\n        \"No in vivo β-cell-specific knockout data\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A comprehensive substrate catalog for GGTase3, the regulatory logic governing partitioning of RABGGTB between GGTase2 and GGTase3, and in vivo loss-of-function phenotypes in specific tissues remain to be determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No unbiased proteomics identifying all GGTase3-prenylated substrates\",\n        \"No structural comparison of GGTase2 versus GGTase3 β-subunit engagement\",\n        \"Conditional knockout of Rabggtb in specific tissues not reported\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [\n      \"GGTase2 (RABGGTA/RABGGTB)\",\n      \"GGTase3 (PTAR1/RABGGTB)\"\n    ],\n    \"partners\": [\n      \"RABGGTA\",\n      \"PTAR1\",\n      \"FBXL2\",\n      \"SKP1\",\n      \"CHODL\",\n      \"RAB7A\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"RABGGTB is the catalytic beta subunit of two distinct protein geranylgeranyltransferase complexes: the canonical Rab geranylgeranyltransferase (RabGGTase, paired with RABGGTA and REP escort proteins) that doubly geranylgeranylates Rab GTPases to direct their membrane targeting and vesicular trafficking, and GGTase-III (paired with PTAR1) that geranylgeranylates non-Rab substrates including FBXL2 and the Golgi SNARE Ykt6 [PMID:8505342, PMID:31209342, PMID:32128853]. Within RabGGTase, RABGGTB catalyzes attachment of two geranylgeranyl groups to C-terminal di-cysteine motifs (CC, CXC, CCXX) of Rab proteins such as Rab1A, Rab5A, Rab6, and Rab27a; this double prenylation is essential for correct organellar targeting and function, as mono-prenylated Rabs are mistargeted and non-functional [PMID:7991565, PMID:12802062]. In the GGTase-III complex, a crystal-structure-defined multivalent interface between PTAR1 and the FBXL2 LRR domain determines substrate specificity, while GGTase-III-dependent double prenylation of Ykt6 is required for Golgi SNARE complex assembly and intra-Golgi trafficking [PMID:31209342, PMID:32128853]. RABGGTB-mediated Rab7 geranylgeranylation also promotes autophagosome–lysosome fusion, and overexpression of RABGGTB in SOD1-G93A ALS mouse models delayed disease onset and reduced protein aggregation [PMID:38042502, PMID:36967828].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of RABGGTB as the catalytic beta subunit of RabGGTase resolved the molecular identity of the enzyme that prenylates Rab GTPases, establishing that it functions as a heterodimer with an alpha subunit and requires the REP escort protein for activity.\",\n      \"evidence\": \"cDNA cloning and heterologous co-expression in 293 cells with reconstituted enzymatic activity; complemented by biochemical fractionation in choroideremia patient lymphoblasts showing separable Component A (REP) and Component B (alpha/beta) activities\",\n      \"pmids\": [\"8505342\", \"8380507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for how RABGGTB engages REP and lipid substrate was unknown\",\n        \"Whether RABGGTB participates in complexes beyond RabGGTase was not considered\"\n      ]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstration that RabGGTase doubly geranylgeranylates Rab C-terminal di-cysteine motifs (CC, CXC, CCXX) and that substrate recognition depends on the hypervariable C-terminal region established the catalytic product and substrate-selection rules for the RABGGTB-containing enzyme.\",\n      \"evidence\": \"In vitro prenylation with HPLC/mass spectrometry of Rab1A, Rab3A, Rab5A tryptic peptides; Rab6 deletion/substitution mutagenesis coupled to prenylation and GDI-extraction assays\",\n      \"pmids\": [\"7991565\", \"8175798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Atomic-level mechanism of double prenylation was unresolved\",\n        \"In vivo functional consequences of mono- versus di-prenylation were unknown\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The crystal structure of isoprenoid-bound RabGGTase–REP-1 revealed the allosteric communication between the lipid-binding site and the REP interface, and cell-biological experiments showed that double geranylgeranylation is required for correct Rab targeting to organelles in vivo.\",\n      \"evidence\": \"X-ray crystallography at 2.7 Å with binding assays; EGFP-Rab mutant localization in HeLa cells, inhibitor treatment, and Rab27a rescue in knockout mice\",\n      \"pmids\": [\"12620235\", \"12802062\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether RABGGTB could function with alternative alpha subunits was not explored\",\n        \"Structural basis for Rab substrate recognition within the active site remained incomplete\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that RABGGTB pairs with the orphan alpha subunit PTAR1 to form a second prenyltransferase (GGTase-III) that geranylgeranylates the non-Rab substrate FBXL2 fundamentally expanded the functional repertoire of RABGGTB beyond Rab biology.\",\n      \"evidence\": \"Co-immunoprecipitation, reconstituted in vitro prenylation, subcellular fractionation, and X-ray crystallography of the GGTase-III–FBXL2–SKP1 ternary complex with mutagenesis\",\n      \"pmids\": [\"31209342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Full substrate scope of GGTase-III was unknown\",\n        \"Physiological contexts where GGTase-III versus RabGGTase activity is limiting were uncharacterized\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of Ykt6 as a second GGTase-III substrate and demonstration that GGTase-III-dependent double prenylation of Ykt6 is required for Golgi SNARE complex assembly established RABGGTB's role in Golgi organization through a non-Rab pathway.\",\n      \"evidence\": \"Biotinylated geranylgeranyl labeling, in vitro prenylation, X-ray crystallography of GGTase-III–Ykt6, gene-knockout cell lines with Golgi trafficking assays\",\n      \"pmids\": [\"32128853\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether additional SNARE or Golgi-resident proteins are GGTase-III substrates is unknown\",\n        \"Relative contribution of RabGGTase versus GGTase-III to overall RABGGTB function in vivo is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Placing RABGGTB-mediated Rab7 prenylation upstream of autophagosome–lysosome fusion linked RABGGTB to autophagic flux, and in vivo overexpression in SOD1-G93A ALS mice was neuroprotective, extending survival and reducing protein aggregation.\",\n      \"evidence\": \"Lentiviral overexpression in ALS cell models with autophagy flux assays; AAV9-mediated spinal cord delivery in SOD1-G93A mice with behavioral, survival, and histological readouts\",\n      \"pmids\": [\"38042502\", \"36967828\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the neuroprotective effect is solely Rab7-dependent or also involves GGTase-III substrates is untested\",\n        \"Findings are from single-laboratory studies and have not been independently replicated\",\n        \"Therapeutic relevance to human ALS is unestablished\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Knockdown of the GGTase-III alpha subunit PTAR1 in pancreatic beta cells severely impaired glucose-stimulated insulin secretion, implicating the RABGGTB-containing GGTase-III complex in regulated exocytosis beyond the nervous system.\",\n      \"evidence\": \"siRNA knockdown of PTAR1 in INS-1 832/13 cells and primary islets with ELISA-based insulin secretion assays\",\n      \"pmids\": [\"40598917\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"RABGGTB itself was not directly knocked down; the effect is inferred indirectly through the alpha subunit\",\n        \"Identity of the GGTase-III substrate(s) responsible for the secretion defect is not established\",\n        \"Independent replication is needed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The complete substrate repertoire of GGTase-III, the structural basis for how RABGGTB partitions between RabGGTase and GGTase-III in the same cell, and the in vivo consequences of selectively disrupting one complex versus the other remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No systematic substrate screen for GGTase-III has been reported\",\n        \"No structural or kinetic model explains competitive assembly of RABGGTB with RABGGTA versus PTAR1\",\n        \"Conditional knockout studies distinguishing RabGGTase from GGTase-III functions in specific tissues are lacking\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 2, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 7]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 2, 7, 8]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [5, 8]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"complexes\": [\n      \"RabGGTase (RABGGTA–RABGGTB)\",\n      \"GGTase-III (PTAR1–RABGGTB)\"\n    ],\n    \"partners\": [\n      \"RABGGTA\",\n      \"PTAR1\",\n      \"CHM\",\n      \"CHML\",\n      \"FBXL2\",\n      \"YKT6\",\n      \"CHODL\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}